Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Stroke

Elucidating the use of enoxaparin in non-ST-elevation acute coronary syndromes (NSTE-ACS)
Martin Mayer

BMJ Evidence-Based Medicine Feb 2016, 21 (1) 4-6; DOI: 10.1136/ebmed-2015-110275
Parent-reported sleep-disordered breathing symptoms early in life predict childhood behavioural problems at age 4 and 7 years
Alice M Gregory, Luci Wiggs

BMJ Evidence-Based Medicine Apr 2013, 18 (2) 77-78; DOI: 10.1136/eb-2012-100821
Current 10-year atherosclerotic cardiovascular disease risk threshold for statin eligibility is cost-effective for primary prevention
Joseph Yeboah

BMJ Evidence-Based Medicine Dec 2015, 20 (6) 230; DOI: 10.1136/ebmed-2015-110277
Blood pressure lowering in patients with type 2 diabetes improves cardiovascular events including mortality, but more intensive lowering to systolic blood pressure less than 130 mm Hg is associated with further reduction in stroke and albuminuria without further reduction in cardiac events
Bora Toklu, Sripal Bangalore

BMJ Evidence-Based Medicine Oct 2015, 20 (5) 183-184; DOI: 10.1136/ebmed-2015-110197
Intensive glucose-lowering results in increased cardiovascular mortality in younger but not older individuals with type 2 diabetes
Francesco Giorgino

BMJ Evidence-Based Medicine Dec 2014, 19 (6) 210; DOI: 10.1136/ebmed-2014-110010
Long-term coffee consumption associated with reduced risk of total and cause-specific mortality
Esther Lopez-Garcia

BMJ Evidence-Based Medicine Jun 2013, 18 (3) 116-117; DOI: 10.1136/eb-2012-100878
For people with non-valvular atrial fibrillation rivaroxaban is non-inferior to warfarin for preventing stroke or embolism, with no difference in the risk of clinically relevant bleeding
Matthew Sherwood, Jonathan P Piccini

BMJ Evidence-Based Medicine Oct 2012, 17 (5) 148-149; DOI: 10.1136/ebmed-2011-100343
Cardiovascular benefits of HRT may differ by patient age
Giuseppe Rosano, Cristiana Vitale

BMJ Evidence-Based Medicine Apr 2014, 19 (2) 61; DOI: 10.1136/eb-2013-101430
Benefits of blood pressure lowering are seen across levels of baseline blood pressure, comorbidity and drug class
Mark R Nelson

BMJ Evidence-Based Medicine Oct 2016, 21 (5) 172; DOI: 10.1136/ebmed-2016-110446
In TIA or stroke patients with intracranial arterial stenosis, aggressive medical therapy was superior to percutaneous transluminal angioplasty and stenting for 30-day risk of further stroke or death
Tim Darsaut, Jean Raymond, Sylvain Lanthier

BMJ Evidence-Based Medicine Aug 2012, 17 (4) 115-116; DOI: 10.1136/ebmed-2011-100451

Pages